SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-22-000117
Filing Date
2022-01-21
Accepted
2022-01-21 17:01:00
Documents
2
Group Members
JEFF EASTONLIND GLOBAL FUND II LLC

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 73891
2 JOINT FILING AGREEMENT exhibit99-1.htm EX-99.1 7678
  Complete submission text file 0000929638-22-000117.txt   83117
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Subject) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-90926 | Film No.: 22546647
SIC: 2834 Pharmaceutical Preparations

Mailing Address 444 MADISON AVENUE 41ST FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 41ST FLOOR NEW YORK NY 10022 646-701-7428
Lind Global Fund II LP (Filed by) CIK: 0001871665 (see all company filings)

IRS No.: 863914253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G